Chardan Capital Reiterates Healthequity Inc to Buy with Price Target $53

Brokerage firm Chardan Capital Reiterates its rating on Healthequity Inc(HQY). As per the latest information, Chardan Capital Raises the price target to $53 per share from a prior target of $50. The shares have been rated Buy. The rating by the stock financial advisor at Chardan Capital was issued on Mar 22, 2017 in a research report to their Investors and Clients.

In a different note, Chardan Capital said it Initiates Coverage On Healthequity Inc, according to a research note issued on Feb 7, 2017. In the research note, the firm Announces the price-target to $47 per share. The shares have been rated ‘Buy’ by the firm. KeyBanc said it Initiates Coverage On Healthequity Inc, according to a research note issued on Jan 23, 2017. In the research note, the firm Announces the price-target to $60 per share. The shares have been rated ‘Overweight’ by the firm.

Healthequity Inc (HQY) shares turned negative on Fridays trading session with the shares closing down -2.15 points or -5.05% at a volume of 11,97,831. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $43.32. The peak price level was also seen at $43.32 while the days lowest was $40.01. Finally the shares closed at $40.4. The 52-week high of the shares is $49.25 while the 52-week low is $21.9. According to the latest information available, the market cap of the company is $2,405 M.

Healthequity Inc(HQY) last announced its earnings results on Mar 21, 2017 for Fiscal Year 2017 and Q4.Company reported revenue of $46.814M. Analysts had an estimated revenue of $45.660M. Earnings per share were $0.07. Analysts had estimated an EPS of $0.05.

Several Insider Transactions has been reported to the SEC. On Mar 21, 2017, Stephen Neeleman (Founder and Vice Chairman) sold 55,518 shares at $46.10 per share price.Also, On Mar 3, 2017, Jon Kessler (President and CEO) sold 30,000 shares at $44.36 per share price.On Feb 22, 2017, Darcy G Mott (Executive VP and CFO) sold 10,000 shares at $42.60 per share price, according to the Form-4 filing with the securities and exchange commission.

HealthEquity Inc. is a provider of a range of solutions for managing health care accounts (Health Savings Accounts (HSAs)) Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings compare treatment options and pricing evaluate and pay healthcare bills receive personalized benefit and clinical information earn wellness incentives and make educated investment choices to grow their tax-advantaged healthcare savings. The Company’s products and services include healthcare saving and spending platform health savings accounts investment advisory services reimbursement arrangements and healthcare incentives.

Add Comment